Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20265 Citations
Lanreotide (Somatuline Depot)8 residuesCVYWKTCTEach bubble = one amino acid. Size = residue mass. Color = chemical class.Lanreotide is an FDA-approved somatostatin analog given once every 28 days for acromegaly and GEP-NETs. The CLARINET trial showed 53% reduced progression risk; PRIMARYS found 63% of patients had tumor shrinkage by 48 weeks. Pre-filled syringe, no reconstitution. GI side effects and gallstone risk require monitoring.
60mcg · Monthly
Summary: Add 0mL BAC water to your 60mg vial. Draw to < 0.1 units on a U-100 syringe for a 60mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 60mg | Monthly |
| Moderate | 90mg | Monthly |
| Aggressive | 120mg | Monthly |
Lanreotide is different from most peptides on this platform. There is no vial to reconstitute, no bacteriostatic water, no insulin syringe math. It arrives as a pre-filled syringe in three strengths: 60 mg (0.3 mL), 90 mg (0.3 mL), and 120 mg (0.5 mL). You inject the full contents. That's it. The catch is that this is a deep subcutaneous injection into the upper outer quadrant of the buttock, not a typical belly or thigh pinch. Many patients have a healthcare provider do it, at least initially. Cold chain matters. Store at 2 to 8 degrees Celsius. Pull the syringe out 30 minutes before injection to reach room temperature; cold gel is thicker and harder to push through the needle. One thing beginners miss: GI side effects in the first month are not a sign that something went wrong. They are expected. Low-fat meals (under 40 g/day) and pancreatic enzyme supplements help considerably. Alternate left and right buttock each month. Superficial injection worsens nodule formation.
Dosing based on Somatuline Depot (lanreotide) FDA Prescribing Information (2024) — 7 published references.View all sources →
Cross-check your Lanreotide (Somatuline Depot) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Lanreotide is an FDA-approved somatostatin analog given once every 28 days for acromegaly and GEP-NETs. The CLARINET trial showed 53% reduced progression risk; PRIMARYS found 63% of patients had tumor shrinkage by 48 weeks. Pre-filled syringe, no reconstitution. GI side effects and gallstone risk require monitoring.
